Regulatory Status and Legal Considerations BPC-157 occupies a complicated regulatory position in the United States
Cell-culture research has shown that reducing NNMT was associated with less lipid accumulation in fat cells, while increasing NNMT was associated with more suggesting NNMT contributes to adipocyte function rather than simply marking metabolic dysfunction
As far as tested athletes are concerned BPC is not currently on the WADA banned list under the section naming peptide hormones, growth factors, related substances, and mimetics (as of October 2020)
Storage Recommendations for Research Use: Store lyophilized BPC-157 at -20C in a sealed, desiccated environment Once reconstituted for laboratory use, maintain at 28C and utilize within established research protocol timeframes Avoid repeated freeze-thaw cycles to preserve peptide integrity for research purposes Keep away from UV light exposure during storage For reconstitution, use sterile bacteriostatic water
This makes it a complementary research compound to IGF-1 receptor studies
AOD 9604 clinical trials showed a tolerability profile statistically indistinguishable from placebo
